https://www.healio.com/primary-care/pain-management/news/online/%7Be367b2f4-7ddc-48fa-93f3-0ccaa5f4738d%7D/axs-07-effective-against-migraine-pain-in-phase-3-intercept-trial
AXS-07 effective against migraine pain in phase 3 INTERCEPT trial
www.MigraineTreatmentReport.com
https://www.healio.com/primary-care/pain-management/news/online/%7Be367b2f4-7ddc-48fa-93f3-0ccaa5f4738d%7D/axs-07-effective-against-migraine-pain-in-phase-3-intercept-trial
AXS-07 effective against migraine pain in phase 3 INTERCEPT trial
https://clinicaltrials.gov/ct2/show/NCT04068051?type=Intr&cond=Migraine&sfpd_d=14&sel_rss=new14
Condition : Migraine
Intervention : Drug: AXS-07
Sponsor : Axsome Therapeutics, Inc.
Recruiting
Open-Label Long-Term Safety Study of AXS-07 for the Acute Treatment of Migraine
NCT04068051
Mon, 26 Aug 2019 12:00:00 EDT
Last Update Posted: 08/28/19 11:26AM
https://clinicaltrials.gov/ct2/show/NCT03896009?type=Intr&cond=Migraine&sfpd_d=14&sel_rss=new14
Condition : Migraine
Interventions : Drug: AXS-07 (MoSEIC meloxicam and rizatriptan); Drug: Meloxicam; Drug: Rizatriptan; Drug: Placebo
Sponsor : Axsome Therapeutics, Inc.
Recruiting
Maximizing Outcomes in Treating Acute Migraine
NCT03896009
Fri, 29 Mar 2019 12:00:00 EDT
Last Update Posted: 03/29/19 09:48AM